Skip to content Skip to navigation

Bench to Bedside: Designing pre-clinical studies to support in-human trials. (Part 2 of 2)

Bench to Bedside: Designing pre-clinical studies to support in-human trials. (Part 2 of 2)

A presentation by Julia Pomoransky, PhD (Turnstone Biologics) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

In this seminar, Dr. Pomoransky discusses the translational continuum of moving pre-clinical studies towards in-human trials. Through a series of examples, Dr. Pomoransky discusses the considerations of pre-clinical development including; pre-clinical POC, GLP toxicology, process and assay development, GMP manufacturing and testing, stability testing and regulatory interactions.

This video was posted by the Ontario Institute for Regenerative Medicine, in partnership with BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research and Stem Cell Network.